Araştırma Makalesi

The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells

Cilt: 3 Sayı: 1 21 Nisan 2020
PDF İndir

The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells

Öz

The goal in the cancer treatment is to induce tumor cell death without damaging healthy cells and to prevent the spread of these cells to other organs. In the case of metastasis, the cure protocols may be inadequate. Alternative methods are used to support treatment. For this purpose, herbal products are widely used. In our experiment, we aimed to investigate the effect of Hypericum crenulatum polysaccharides on the proliferation of breast cancer cell lines. Hypericum crenulatum polysaccharides were isolated and were exposed to the MCF-7 and MDA-MB-231 cells  at different dilutions,  then IC50 doses for each cells were calculated using MTT assay. Breast cancer cells were treated with IC50 doses of polysaccharides for 24 hours and immunocytochemistry was performed to evaluate the expressions of metastases and proliferation markers, PI3K, Akt-1 and Erk-1/2. The staining results were evaluated by H-score and the difference between the groups was analyzed statistically. Hypericum crenulatum polysaccharides were found to be toxic to both breast cancer cells by MTT method. When PI3K, Akt-1 and Erk-1/2 markers of proliferation and metastasis were evaluated, it was seen that there was a significant decrease compared to the control group. Since MDA-MB-231 cells are ER (-), their invasion ability is over compared to MCF-7 ER (+)  cells. For this reason, the toxic effect of polysaccharides was found to be higher in MCF-7 cells. As a result, in vivo studies are needed to be performed following the the antiproliferative effects of herbal products are found in vitro.

Anahtar Kelimeler

Kaynakça

  1. 1. Hasegawa T, Adachi R, Iwakata H, Takeno T, Sato K, Sakamaki T. ErbB2 signalingepigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer. FEBS Open Bio 2017; 7(8):1154-1165. doi:10.1002/2211-5463.12256.
  2. 2. Gagliato DM, Jardim DL, Marchesi MS and Hortobagyi GN. Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer. Oncotarget 2016; 7, 64431–64446.
  3. 3. Liu S, Chen S, Yuan W, Wang H, Chen K, Li D, Li D. PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways. Oncotarget 2017; 8(59):99901-99912. doi:10.18632/oncotarget.21914.
  4. 4. Han R, Gu S, Zhang Y, Luo A, Jing X, Zhao L, Zhao X, Zhang L. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling. Sci Rep 2018; 8(1):9575. doi: 10.1038/s41598-018-27810-6.
  5. 5. Weigelt B, Warne PH and Downward J. PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene 2011; 30, 3222–3233.
  6. 6. Adamczyk A, Niemiec J, Janecka A, Harazin- Lechowska A, Ambicka A, Grela-Wojewoda A, Domagala-Haduch M, Cedrych I, Majchrzyk K, Kruczak A et al. Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. Pol J Pathol 2015; 66, 133–141.
  7. 7. Qin H, Liu L, Sun S, Zhang D, Sheng J, Li B, Yang W. The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment. PeerJ 2018; 6:e5092. doi: 10.7717/peerj.5092.
  8. 8. Franco P, Rampino M, Ostellino O, Schena M, Pecorari G, Garzino Demo P, Fasolis M, Arcadipane F, Martini S, Cavallin C, Airoldi M, Ricardi U. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients. Med Oncol 2017; 34(2):30. doi: 10.1007/s12032-017-0886-5.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

21 Nisan 2020

Gönderilme Tarihi

15 Kasım 2019

Kabul Tarihi

25 Aralık 2019

Yayımlandığı Sayı

Yıl 2020 Cilt: 3 Sayı: 1

Kaynak Göster

APA
Aydemir, İ., Ozkan, O., & Savran, A. (2020). The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells. Ege Tıp Bilimleri Dergisi, 3(1), 1-6. https://doi.org/10.33713/egetbd.647464
AMA
1.Aydemir İ, Ozkan O, Savran A. The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells. AEGEAN J MED SCI. 2020;3(1):1-6. doi:10.33713/egetbd.647464
Chicago
Aydemir, İşil, Oktay Ozkan, ve Ahmet Savran. 2020. “The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells”. Ege Tıp Bilimleri Dergisi 3 (1): 1-6. https://doi.org/10.33713/egetbd.647464.
EndNote
Aydemir İ, Ozkan O, Savran A (01 Nisan 2020) The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells. Ege Tıp Bilimleri Dergisi 3 1 1–6.
IEEE
[1]İ. Aydemir, O. Ozkan, ve A. Savran, “The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells”, AEGEAN J MED SCI, c. 3, sy 1, ss. 1–6, Nis. 2020, doi: 10.33713/egetbd.647464.
ISNAD
Aydemir, İşil - Ozkan, Oktay - Savran, Ahmet. “The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells”. Ege Tıp Bilimleri Dergisi 3/1 (01 Nisan 2020): 1-6. https://doi.org/10.33713/egetbd.647464.
JAMA
1.Aydemir İ, Ozkan O, Savran A. The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells. AEGEAN J MED SCI. 2020;3:1–6.
MLA
Aydemir, İşil, vd. “The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells”. Ege Tıp Bilimleri Dergisi, c. 3, sy 1, Nisan 2020, ss. 1-6, doi:10.33713/egetbd.647464.
Vancouver
1.İşil Aydemir, Oktay Ozkan, Ahmet Savran. The effects of Hypericum crenulatum polysaccharides on the proliferation of cancer cells. AEGEAN J MED SCI. 01 Nisan 2020;3(1):1-6. doi:10.33713/egetbd.647464

Cited By

Bu dergide yayınlanan makaleler, Creative Commons Atıf-Gayriticari 4.0 (CC BY-NC 4.0) Uluslararası Lisansı ile Lisanslanmıştır.